DIAMEDICA THERAPEUTICS INC

DiaMedica Therapeutics (DMAC) Stock Rises 11% MTD to $8.72 Amid Strong 24‑Hr Peer Gains

Diamedica Therapeutics (DMAC) shares jump 11.37% MTD, now at $8.72. Learn about its stroke & kidney drug pipeline, market cap, and peer comparison.

DIAMEDICA THERAPEUTICS INC
United States
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

Elliot Mercer

26/10/2026, 13:37

One minute to read

Diamedica Therapeutics Shares Surge 10% as 200‑Day MA Support Boosts Bullish Outlook

DMAC’s 10% jump above the 200‑day SMA signals a bullish trend for Diamedica Therapeutics, spotlighting its niche stroke‑kidney pipeline and strong market momentum.

DIAMEDICA THERAPEUTICS INC
United States
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

Jake Connors

21/10/2026, 23:04

3 minutes to read